What Vivactis does

Vivactis Group is an independent, privately-held healthcare consulting group operating as Newton 21 Europe s.a., headquartered in Auderghem (Brussels), Belgium. Founded in 1994, the company has built a 250-person organization across more than 20 specialized agencies with direct presence in Belgium, France, Switzerland, Spain, Italy, the United Kingdom, and Mexico. Its services span the full pharmaceutical value chain — from research and development support through pre-launch, launch, growth, maturity, and loss of exclusivity — covering brand strategy, marketing communications, medical education, clinical trials coordination, market access and health economics, public relations, scientific publishing, and event management.

The group's core offering is delivered through five interconnected business units: Clinical Trials & Market Access (including Phase I–III setup and pharmacovigilance coordination), MarkCom & MedEd Agency (scientific content, e-learning, training), Publication & Edition (medical press and digital communications), Digital (online healthcare communications), and an International Hub (central coordination of multinational projects). Specialized service brands include Vivactis Market Access and Hyperverse International (congress and event management, including virtual events). The company's go-to-market is enterprise field sales: bespoke consulting engagements sold directly to large and medium pharmaceutical, biotech, and MedTech companies, as well as patient and scientific associations, with global reach supplemented through partnerships with WorldWide Partners and United Partners.

Vivactis monetizes through professional services fees on customized consulting engagements, with no public pricing or productized offering. Its customer base includes more than 25 named enterprise logos spanning top-tier global pharma (Pfizer, Roche, Novartis, Merck, AstraZeneca, GSK, AbbVie, BMS, Sanofi ecosystem, Takeda), MedTech (Medtronic, Philips), biotech (Alnylam, Vertex, Galapagos, Horizon), and consumer health/medical devices (Abbott, Reckitt, Ramsay). The firm is 100% pharma/MedTech/healthcare focused, 100% independent, and appears to be founder/management-owned with no disclosed external investors or parent company.

Name

Vivactis

Legal name

Newton 21 Europe s.a.

Website

https://vivactis.com

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Healthcare Communications Consulting

NAICS

Management Consulting Services (54161), Marketing Consulting Services (541613), Advertising, Public Relations, and Related Services (5418), Other Management Consulting Services (541618)

SIC

Services-Management Consulting Services (8742), Services-Advertising Agencies (7311), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)

Keywords

• Healthcare consulting
• Pharmaceutical communications
• Medical education
• Market access
• Clinical trials coordination

Headquarters

HQ city

Courbevoie

HQ country

France

HQ region

Europe

Offices9 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Healthcare Consulting Services: Professional consulting services provided across the pharmaceutical value chain, including brand strategy, medical education, clinical trials coordination, market access, and scientific communications for pharma, biotech, MedTech companies, and healthcare associations.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Vivactis Group is an independent international consulting group providing healthcare communications and consulting services across the entire pharmaceutical value chain, from R&D through loss of exclusivity. The group delivers brand strategy, medical education, clinical trials coordination, market access, scientific communications, and digital/e-learning solutions to pharmaceutical, biotech, MedTech companies, and healthcare associations through a network of 20+ specialized agencies across Europe and Mexico.

Product overview

Vivactis Group is an independent consulting group operating as a multi-national, multi-cultural organization that delivers services across the entire pharmaceutical value chain. The group comprises a network of more than 20 specialized and interconnected agencies across Europe (Benelux, France, Italy, Spain, Switzerland, UK) and Mexico, organized into distinct business units including Clinical Trials & Market Access, MarkCom & MedEd Agency, International Hub, Publication & Edition, Digital, and International Congress. The portfolio includes regional agencies (Vivactis Benelux, Vivactis France, Vivactis Italy, Vivactis Innuo, Vivactis Simed, Vivactis Switzerland, Vivactis UK), specialized service brands (Vivactis Market Access, Hyperverse International), and subsidiary agencies (Medisquare, Vivio, Hyperverse, RMN Group, Newway, Qualissima, Media For Health). Services span brand strategy, marketing & communication, medical education, public relations, clinical trials/CRO, health economics, and scientific events management.

Differentiator

Problem solved

Functional benefit

Brands

• Vivactis Benelux: Healthcare communications and consulting operations in Belgium and Luxembourg
• Vivactis France
• Vivactis Switzerland
• Vivactis Italy
• Vivactis UK
• Vivactis Innuo
• Vivactis Simed
• Vivactis Market Access
• Vivactis Media For Health
• Vivactis Advance
• Vivactis Innovations
• Vivactis Qualissima
• Vivactis Vivio France
• Medisquare
• Vivio
• Hyperverse
• Newway
• RMN Group
• Qualissima

Named customers29 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered core.

• WorldWide Partners (WPI)coreStrategic or Co-development PartnerInternational partnership network enabling Vivactis to provide global campaign capabilities through association with other independent agencies worldwide.
• United PartnerscoreStrategic or Co-development PartnerStrategic partnership with European network of independent agencies enabling expanded geographic coverage and capabilities for multinational client campaigns.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Inizio (formerly Huntsworth Health): Global healthcare communications and consulting group (formerly Huntsworth, now owned by CD&R) offering medical communications, market access, and patient engagement to pharma and biotech — directly comparable to Vivactis in service mix, though larger and globally scaled.
• Healthware Group: Independent healthcare consultancy and communications group with operations across Europe, UK, and US, providing medical communications, digital health, and transformation consulting. Closest mid-sized independent comparable to Vivactis in service breadth and target clients.
• Lucid Group: Independent medical communications and strategic consulting group (now part of the Lucid Group / Lumanity), serving global pharma with MedComms, market access, and patient engagement. Closest mid-sized direct competitor to Vivactis's MarkCom & MedEd and market access services.
• Cello Health (now part of PharmaLex): Healthcare strategic consulting and communications firm providing brand strategy, medical communications, and market access to global pharma. Comparable mid-sized independent competitor to Vivactis, recently acquired by PharmaLex to scale globally.

Broad incumbents

• Publicis Health: Health-focused arm of Publicis Groupe providing advertising, medical communications, media, and digital health services to pharma clients globally. Operates overlapping service lines to Vivactis (MedEd, brand strategy, digital) but at significantly larger scale and with full agency network capabilities.
• Omnicom Health Group: Network of healthcare communications agencies under Omnicom (CDM, FCB Health, DDB Health). Directly comparable services (medical education, brand communications, market access) but with global footprint and integrated media buying Vivactis lacks.
• Havas Health & You: Havas-owned global healthcare communications network providing creative, medical, and digital services to pharma and consumer health clients. Overlaps Vivactis on medical communications, brand strategy, and patient engagement at greater scale.
• Ogilvy Health: WPP-owned healthcare communications network offering brand strategy, medical education, and patient engagement globally. Comparable to Vivactis on scientific content and brand work, but with WPP's data, media, and production scale.
• McCann Health: Interpublic-owned global healthcare communications network (McCann Health, FCB Health) providing medical communications, brand strategy, and market access. Direct overlap with Vivactis on MedEd and brand work, larger global scale.

Emerging players

• MedThink Communications: US-based healthcare communications agency serving pharma, biotech, and MedTech with medical communications and strategic services. Direct overlap with Vivactis's brand and MedEd services, but smaller scale and US-focused.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/65073

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles15 records

Subsidiaries17 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vivactis